USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
NAJIT TECHNOLOGIES, INC.
Address:
505 NW 185th Avenue
Beaverton, OR
Phone:
N/A
URL:
N/A
EIN:
201102310
DUNS:
147965243
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $585,202.00 1
SBIR Phase II $2,986,707.00 1
STTR Phase I $499,382.00 1

Award List:

Development of a Yellow Fever Vaccine for Vulnerable Populations

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$585,202.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Yellow fever virus (YFV) was at one time endemic in the United States and represents an emerging/re-emerging human pathogen that causes up to 20% mortality. Although YFV is typically spread by the bite of Aedes aegypti mosquitoes, it also represents a viralā€¦ More

Development of a Yellow Fever Vaccine for Vulnerable Population

Award Year / Program / Phase:
2011 / SBIR / Phase II
Award Amount:
$2,986,707.00
Agency:
HHS
Principal Investigator:
Ian J. Amanna – 503-466-3895
Abstract:
DESCRIPTION (provided by applicant): Yellow fever virus (YFV) was at one time endemic in the United States and represents a mosquito-borne emerging/re-emerging human pathogen that causes up to 20% mortality. The current live attenuated YFV vaccine was developed in 1936 and following the developmentā€¦ More